240 related articles for article (PubMed ID: 6294999)
1. [Catecholamines in the therapy of chronic cardiac insufficiency].
Brandt D; Klein W
Wien Med Wochenschr; 1982 Oct; 132(19):450-6. PubMed ID: 6294999
[No Abstract] [Full Text] [Related]
2. [The use of beta-1-adrenergic agonists in the treatment of cardiac insufficiency].
Coulombe D
Ann Cardiol Angeiol (Paris); 1984; 33(4):207-10. PubMed ID: 6147113
[TBL] [Abstract][Full Text] [Related]
3. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
Rae AP; Tweddel AC; Hutton I
Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
Shevchenko VA
Vrach Delo; 1983 Oct; (10):8-12. PubMed ID: 6139918
[No Abstract] [Full Text] [Related]
5. [Catecholamines for treatment of severe heart failure (author's transl)].
Mäurer W; Tillmanns H; Kübler W
Z Kardiol; 1979 May; 68(5):290-7. PubMed ID: 223342
[TBL] [Abstract][Full Text] [Related]
6. [Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Kleinschmidt R; Spannbrucker N; Vogel F
Dtsch Med Wochenschr; 1985 Apr; 110(15):598-603. PubMed ID: 2983969
[No Abstract] [Full Text] [Related]
7. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
8. [New drugs with positive inotropic action].
Bijak A; Czołpiński T
Kardiol Pol; 1982; 25(4):357-65. PubMed ID: 6128439
[No Abstract] [Full Text] [Related]
9. [Sympathomimetics in intensive medicine].
Vogel F; Spannbrucker N; Bodem G
Dtsch Med Wochenschr; 1981 Oct; 106(42):1383-5. PubMed ID: 7285817
[No Abstract] [Full Text] [Related]
10. [Therapy of heart failure with beta adrenoceptor agonists].
Klein G; Wirtzfeld A; Schnelle K
MMW Munch Med Wochenschr; 1983 Apr; 125(14):277-80. PubMed ID: 6134232
[No Abstract] [Full Text] [Related]
11. Use of catecholamines in acute myocardial infarction.
Dixon DW; Loeb HS; Gunnar RM
Herz; 1979 Oct; 4(5):385-96. PubMed ID: 391685
[TBL] [Abstract][Full Text] [Related]
12. New catecholamines in clinical cardiovascular medicine.
Leier CV
Kardiol Pol; 1980; 23(9):721-5. PubMed ID: 7441942
[No Abstract] [Full Text] [Related]
13. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
Kenakin TP; Beek D
J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
[No Abstract] [Full Text] [Related]
14. Acute effects of beta 1 agonism with prenalterol on catecholamine circulating levels in patients with congestive heart failure.
Corea L; Bentivoglio M; Verdecchia P; Provvidenza M
G Ital Cardiol; 1983 Nov; 13(11):330-4. PubMed ID: 6141975
[TBL] [Abstract][Full Text] [Related]
15. Use of catecholamines in pediatrics.
Zaritsky A; Chernow B
J Pediatr; 1984 Sep; 105(3):341-50. PubMed ID: 6147401
[No Abstract] [Full Text] [Related]
16. Cardioselectivity of dobutamine and prenalterol in the pentobarbital anesthetized dog.
Strosberg AM; Montgomery W
Proc West Pharmacol Soc; 1981; 24():83-7. PubMed ID: 7255492
[No Abstract] [Full Text] [Related]
17. Inotropic agents in the treatment of cardiogenic shock.
Bourdarias JP; Dubourg O; Gueret P; Ferrier A; Bardet J
Pharmacol Ther; 1983; 22(1):53-79. PubMed ID: 6361798
[No Abstract] [Full Text] [Related]
18. [Currently used positive inotropic substances].
Hauf GF; Grom E
Ther Umsch; 1984 Feb; 41(2):111-6. PubMed ID: 6369614
[No Abstract] [Full Text] [Related]
19. [Positive inotropic agents. Generalities and classification].
Vahanian A; Le Potier J; Sergent J; Michel PL; Acar J
Ann Med Interne (Paris); 1985; 136(3):242-6. PubMed ID: 2862822
[TBL] [Abstract][Full Text] [Related]
20. [Therapy of acute heart failure].
Autenrieth G
Internist (Berl); 1986 May; 27(5):279-87. PubMed ID: 3089962
[No Abstract] [Full Text] [Related]
[Next] [New Search]
